CVS Health Corporation (LON:0HRS)
London · Delayed Price · Currency is GBP · Price in USD 74.72
+0.54 (0.72%)
At close: Jan 30, 2026
CVS Health Market Cap
CVS Health has a market cap or net worth of 68.95 billion as of January 30, 2026. Its market cap has increased by 28.60% in one year.
Market Cap
68.95B
Enterprise Value
120.49B
Revenue
291.39B
Ranking
n/a
PE Ratio
197.63
Stock Price
74.72
Market Cap Chart
Since July 20, 1992, CVS Health's market cap has increased from 2.51B to 68.95B, an increase of 2,643.95%. That is a compound annual growth rate of 10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 68.95B | -7.88% |
| Dec 31, 2025 | 74.85B | 65.89% |
| Dec 31, 2024 | 45.12B | -43.44% |
| Dec 29, 2023 | 79.77B | -21.50% |
| Dec 30, 2022 | 101.63B | 0.98% |
| Dec 31, 2021 | 100.64B | 53.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.75B |
| GSK plc | 74.30B |
| Haleon | 33.10B |
| Smith & Nephew | 10.31B |
| Convatec Group | 4.47B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.03B |
| HUTCHMED (China) | 1.89B |